The report highlights Biogen's commitment to responsible business practices, including advancing health equity, supporting a diverse and inclusive workforce, and promoting environmental sustainability. The company highlights its progress in developing innovative medicines, expanding access to healthcare, and engaging with stakeholders. Specific achievements include the launch of four new first-in-class medicines, the expansion of SPINRAZA® availability to 70 countries, including 21 low- and middle-income countries, and the certification of 100% of Biogen's labs through the My Green Lab program.
Issuing Company Biogen Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 8.86 MB
No. of Pages 84 pages
Reporting periodJanuary 1, 2023-December 31, 2023
Report EditionUnknown
Assurance Provider Environmental Resources Management Certification and Verification Serv...
Reporting Standards GRI; SASB; TCFD
Materiality Assessmenttrue